1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
DrazCanna, Inc.

DrazCanna, Inc.

DZCA
DrazCanna, Inc.US flagOther OTC
0.01
USD
- -
- -
129,345.00Market Cap
2002 Y
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.12
0.61
0.24
Basic EPS, GAAP
-22.85
-58.79
-136.78
-96.71
-110.02
-157.28
-74.14
-65.89
-96.36
-13.82
-1.32
-1.45
-1.95
-0.67
Free Cash Flow per Basic Share
-13.47
- -
-30.58
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.01
-0.85
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-203.26
-1,002.49
-658.65
-608.29
-639.13
-729.49
-798.27
-757.02
-111.9
-24.1
-8.55
-6.94
-4.33
-2.31
Tangible Book Value per Share
-5.78
-27.15
-25.05
1.33
-48.16
7.11
-67.08
-66.33
-31.47
-2.52
-0.56
-1.47
0.54
-0.18
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
4
8
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,155.86
-225.44
-275.19
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
Net Income, GAAP
- -
- -
- -
- -
-1
-1
- -
- -
-2
-4
-1
-2
-7
-6
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,195.66
-318.02
-279.1
Working Capital
- -
- -
- -
- -
- -
-3
-3
-4
-1
-1
- -
-2
3
-1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
- -
-1
4
1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'16
Dec'16
Mar'16
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
1
1
1
Shares Outstanding
8
8
9
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Sep'16
Dec'16
Mar'16
Total Current Assets
4
2
1
Cash, Cash Equivalents & STI
3
1
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
1
1
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
1
1
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-624.85%
-142.76%
-792.03%
Free Cash Flow
- -
- -
-58.86%
Net Income, GAAP
83.35%
160.38%
291.04%
Sales/Revenue/Turnover
- -
- -
1,370.2%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2014
- -
- -
- -
- -
- -
2015
1
1
1
1
2
2016
1
- -
1
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2014
-0.42
- -
- -
- -
-1.45
2015
-0.83
-0.53
-0.86
- -
-1.95
2016
-0.14
-0.14
-0.19
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Jihad Mohammad
Full Time Employees
31
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
7380 West Sand Lake Road Orlando FL United States of America 32819
IPO Date
Jan 19, 1999
Website
drazcanna.com
Similar Companies
Dali Pharmaceuticalco.,Ltd (603963.SS)
Sun Pharma Advanced Research Company Limited (SPARC.BO)
Laxai Pharma, Ltd. (LAXAF)
Teligent, Inc. (TLGTQ)
Hikal Limited (HIKAL.NS)
Planet 13 Holdings Inc. (PLNHF)
Business
DrazCanna, Inc. is presently undergoing a significant transformation, with its primary focus shifting towards the burgeoning electric vehicle sector through a reverse merger with EV Electra LTD. The company is in the process of transitioning its corporate identity, including a proposed name change to EV Electra LTD, to better reflect its renewed business direction. This strategic pivot establishes DrazCanna as an emerging participant in the e-mobility market, dedicated to designing and manufacturing Battery Electric Vehicles (BEVs). The mission involves developing accessible and sustainable electric vehicles, such as the Emily GT and PONS platforms, emphasizing environmental conservation and zero-emission solutions. This new path follows previous strategic evolutions; the entity previously operated within the educational sector as Global Personalized Academics, providing virtual and in-classroom learning tools globally for K-12 students. After a period as a public shell corporation, it also briefly ventured into the cannabis bio-pharmaceutical research and development supply chain. Now centered on innovative and modular production in the electric vehicle industry, with R&D in Europe, management in the Middle East, and production facilities in Turkey, the company aims to become a leading global EV manufacturer. DrazCanna, Inc. maintains its operational base in Dearborn Heights, Michigan.

Company News

APIChat

  • accesswire.com

    EV Electra Secures Future of Emily and PONS Projects through Acquisition from NEVS

  • accesswire.com

    EV Electra to Unveil Strategic Milestone at eCarExpo in Gothenburg, Sweden

  • accesswire.com

    DrazCanna, Inc. announces Change of Control, Change of Business Direction, and Corporate Actions